While Q215 stevia revenue was below our forecasts, net results matched our expectations of an adjusted C$0.11 EPS loss. We expect margins to improve in the coming quarters, through increased LHG sales and overall capacity utilisation, and the deployment of higher extract-yielding proprietary stevia leaf. We continue to anticipate GLG Life Tech Corporation (TO:GLG) will reach break-even EBITDA in 2016 and generate positive operating income in 2017.
To Read the Entire Report Please Click on the pdf File Below.